Skip to content
Sign in
Business opportunities for Defined Bioscience

Compatibility /100

67/100

High potential

Why talk

  1. Legit.Health has raised about $5.7M — investor introductions are realistic.
  2. Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.
  3. Defined Bioscience likely needs a first foreign market — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).

Score anatomy

Each segment is what one dimension adds, out of 100.

Needs ↔ offers12.3Market bridge2.5Customer potential4.3Sector synergy12.8Stage complementarity35.0

Dimension by dimension

Needs ↔ offers

12.3 / 35 pts

Legit.Health can help Defined Bioscience.

  • Defined Bioscience likely needs a first foreign market — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).

Market bridge

2.5 / 10 pts

Distant markets.

  • Legit.Health is based in Spain (Europe): a landing pad on another continent, both ways.

Customer potential

4.3 / 5 pts

Strong customer or channel potential.

  • Legit.Health has strong traction in a related sector (HealthTech): CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships Defined Bioscience can learn from or tap.

Sector synergy

12.8 / 15 pts

Complementary sectors.

  • Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.

Stage complementarity

35.0 / 35 pts

Strong mentoring / investor-intro potential.

  • Legit.Health has raised about $5.7M — investor introductions are realistic.
  • Legit.Health (Seed) is one step ahead of Defined Bioscience (Pre-seed) — the freshest playbook for Defined Bioscience's next round.

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Investment”: Needs ↔ offers 35, Market bridge 10, Customer potential 5, Sector synergy 15, Stage complementarity 35. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 63/100 — high from 50, medium from 36.